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Thispaperdescribesrecentdataontheeﬀectsofvariousskinformulationscontaininghydroxyacids(HAs)andrelatedproductson
sun-exposedskin.Themostfrequentlyusedclassesoftheseproducts,suchasα-andβ-hydroxyacids,polyhydroxyacids,andbionic
acids,arereviewed,andtheirapplicationincosmeticformulationsisdescribed.Specialemphasisisdevotedtothesafetyevaluation
of these formulations, particularly on the eﬀects of their prolonged use on sun-exposed skin. We also discuss the important contri-
bution of cosmetic vehicles in these types of studies. Data on the eﬀects of HAs on melanogenesis and tanning are also included.
Up-to-date methods and techniques used in those explorations, as well as selected future developments in the cosmetic area, are
presented.
1.Introduction
The cosmetic market is growing rapidly internationally and
shows no sign of slowing in the foreseeable future. Within
skin care products, antiaging and sun protection products
are the main driving forces in this trend. Contemporary cos-
metics contain a large number of active ingredients, such as
botanicals, antioxidants, hormones, and hydroxyacids (HAs)
to name just a few. In this paper, we focus on the role that
HAs play in cosmetic/skin care products, their safety evalua-
tions, and their eﬀects on sun-exposed skin. This paper cov-
ers selected new developments in the ﬁeld which appeared
since our previous review of this topic, and it also includes
selected topics not covered in that paper [1].
2. Presentationof HAs Structure
andClassiﬁcation
HAs have signiﬁcantly inﬂuenced skin care since their intro-
duction to dermatology about 40yrs ago [2]. Since their
inclusion in cosmetic formulations, they have been used to
treat acne, ichthyosis, keratoses, psoriasis, photoaged skin
and other disorders [3]. Following these developments, HAs
have been gradually added into a variety of cosmetic pro-
ducts for daily use and over extended time periods [4]. At
present, glycolic acid, lactic acid, and salicylic acid are the
most frequently used HAs in cosmetics. One of the most
cited beneﬁcial eﬀects of HAs is the reported improvement
of photoaged skin. The driving force behind the increase in
HAs use in cosmetic dermatology and skin care systems has
been their antiaging eﬀects [5]. Based on their structure and
function,HAscanbeclassiﬁedasα-HAs,β-Has,andsalicylic
acid (SA) and its derivatives. The most common representa-
tiveofanα-HAisglycolicacid,whichwasoneoftheﬁrstHAs
to be incorporated into cosmetic formulations [4]. Another
α-HAbeingusedinvarioustopicalformulationsislacticacid
(L-form).
Representatives of β-HAs are hydroxybutanoic acid,
malic acid, and citric acid. Citric acid is presently widely
used in various cosmetic formulations as an antioxidant [6].2 Dermatology Research and Practice
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Figure 1: Structures of selected α-HAs, β-HAs, salicylic acid, and coumaric acid and two representatives of polyhydroxy acids, lactobionic
acid, and gluconolactone.
SA and its derivatives are widely used in contemporary
cosmetic formulations. In the cosmetic and dermatologic
literature, SA is frequently described as a β-HA. As presented
in a paper by Yu and van Scott, this classiﬁcation is incorrect
[7].SAdoesnotfunctionasaβ-HAaccordingtoitschemical
structure or by its biological or physiological function [7].
Polyhydroxy acids (PHAs) and polyhydroxy bionic acids
(PHBAs) constitute more recent arrivals into the cosmetic
domain. They constitute a new generation of HAs with mul-
tiple skin beneﬁts, making them very popular in cosmetic/
skin care products. Structures of selected HAs are presented
in Figure 1.
3. Effects of Formulations ContainingHAs
Due to the rapid proliferation of HAs into the cosmetic
world, safety evaluations of these products have became a
crucial public health issue. As an important contribution to
this problem, the Cosmetic Ingredient Review (CIR) Expert
Panel assessed the available evidence and determined that
α-HA ingredients are not reproductive or developmental
toxins, mutagenic or carcinogenic, and skin sensitizers [8].
Furthermore, the CIR Panel recommended concentration (a
maximum of 10%) and pH (at or above 3.5) in cosmetic
formulations containing α-HAs. In addition, the CIR Panel
recommendedthatHA-containingproductsshouldbeform-
ulated to avoid enhancing sun sensitivity and that consumers
should be advised to use daily sun protection [8]. Several
yearslater,thesameCIRPanelevaluatedproductscontaining
SA and salicylates and recommended that sensitivity to
sunlight be taken into account when developing cosmetic
formulations which was also the same recommendation pro-
vided in the initial assessment of α-HA-containing products
[8, 9].
Knowledge of the involvement of any cosmetic/skin care
product in the induction of photocarcinogenesis is still in
its infancy. The largest and most comprehensive study so
far, sponsored by the National Toxicology Program (NTP),
reported on the photocarcinogenic potential of HAs [10].
The authors reported that glycolic acid did not modify the
photocarcinogenesis induced by SSR, while SA (4%, cos-
metic concentration) was photoprotective.
An important contribution tothis ﬁeld was recentlypub-
lished by Lu et al. [11]. They tested four commercially avail-
able moisturizing creams in their mouse model and found
that, when applied topically to the mice, all the products
had tumorigenic activity. This paper presents an important
ﬁndinganddeservestobediscussedherebrieﬂy.Theconcern
about various eﬀects of cosmetic creams on the skin is not
entirely new. A number of published papers and clinical
studies, including the above-mentioned NTP study, have
suggested that there is a measurable inﬂuence of various
applied cosmetic vehicles on cutaneous responses to UVR
exposure. The protocol applied by Lu et al. diﬀers signiﬁ-
cantly from previously reported approaches. Lu and his team
applied the four selected creams to mice with a high risk
of developing skin tumors without UVB exposure (termed
high-risk mice) after the initial 3 months of exposure. In this
case, the observed results cannot be explained by a vehicle
eﬀectontheopticalpropertiesofskin.Theirpaper,therefore,
raises the question of whether these agents are more active
compounds (tumor promoters). It was expected that suchDermatology Research and Practice 3
ﬁndings would result in immediate reactions. Two commen-
taries on Lu’s paper were published in the same issue of the
journal. The ﬁrst commentary, by Staeb et al. [12], criticized
the design of the experiments; the second commentary,
by Ellefson [13], questioned the statistical approach. Both
groups expressed some doubts about the validity of the
ﬁndings of Lu et al. A third commentary, by Forbes [14], dis-
cussed the paper and provided a brief overview of the ﬁeld.
It is obvious that more studies of this kind are needed. The
most important question emerging from this challenging
laboratory data, however, is the relevance of these ﬁndings to
humans. The cosmetic market is by no means static, and new
products, including HAs and their derivatives, are steadily
entering into the already large cosmetic repertory. A few
examples will be highlighted here. Seo et al. [15] examined
the eﬀects of p-coumaric acid (PCA), a hydroxy derivative
of cinnamic acid, on erythema and pigmentation in UV-
exposed human skin. Twenty-one subjects, with the Fitz-
patrick skin types III-IV, were included in the investigation.
TheauthorsreportthattopicallyappliedPCApreventedUV-
induced erythema and subsequent pigmentation in human
skin. The authors speculated that PCA may suppress the
induction of erythema by altering gene expression or by low-
eringtheUV-inducedinﬂammation.Inaddition,theauthors
suggested that PCA also acts as a potent tyrosinase inhibitor.
In conclusion, Seo et al. stated that the product showed no
apparent adverse reactions and, therefore, may be a useful
active ingredient in cosmetic formulations. Im et al. [16]
investigated the physicochemical properties of fatty ester
derivatives of SA for UV protection. Octanoyl, nonanoyl,
decanoyl, laurel, myristoyl, and palmitoyl oxysalicylate
(C16SA) were investigated. The authors concluded that the
C16SAwasreadilyhydrolyzedtoitsparentcompoundinskin
homogenates, suggesting that it might be converted to SA
after topical administration. Furthermore, it showed the
lowest permeation of SA in all types of skin and a lower
accumulation and smaller uptake in the lipid phase as com-
pared with the other derivatives examined. On the basis of
the reported ﬁndings, they suggested that C16SA could be a
potential candidate for UV protection. Another application
of a SA derivative was recently reported by Merinville et al.
[17]. They provided evidence that sodium salicylate (SS)
obtained from the neutralization of 1% SA with sodium hy-
droxide can deliver satisfactory antiaging beneﬁts, with sig-
niﬁcantly reduced skin irritation, which commonly occurs
following application of SA to sensitive skin. They conducted
three clinical studies, and by measuring biological, optical,
andobservationalbiomarkerstheycoulddemonstratesignif-
icant anti-aging eﬀects of SS, which is especially suitable for
subjects with sensitive skin.
Recently, Tasic-Kostov et al. [18]c o n d u c t e das t u d yt o
assess the safety and eﬃcacy of lactobionic acid as compared
to glycolic acid. Seventy-seven volunteers participated in the
project, and skin color (erythema and melanin index), trans-
epidermal water loss, electrical capacitance, and pH of the
skin were measured. The authors conﬁrmed that lactobionic
acid resulted in improved skin beneﬁts as compared with
corresponding glycolic acid formulations, particularly with
respect to skin irritation and barrier impairment.
4. PresentApplicationsand
FutureDevelopments
Determining a person’s sensitivity to sunlight is critical to
understanding the UV eﬀects of formulations with HAs. The
MED is typically determined on each individual to assess
their UV sensitivity in conjunction with knowledge of the
Fitzpatrick skin type [19]. The Commission Internationale
de L’´ eclairage (CIE) currently has a technical committee
formed to address typical MEDs for individuals of all skin
types, and their technical report will be forthcoming with
recommendations and guidelines (http://div6.cie.co.at/?i ca
id=609&pubid=318) .T h eM E Dp a r a m e t e ra l l o w so n et o
comparebiologicallyequivalenteﬀectsresultingfrom1MED
to previous data in the literature. Typically, a series of ex-
posures of increasing doses is used for MED determination
a sd e s c r i b e di np r e v i o u ss t u d i e s[ 20–24]. Subject photo-
type, site area size, geographical skin location, site-speciﬁc
melanin content, and UV source vary by clinical study and
present speciﬁc challenges when determining the MED. To
allow for comparison across clinical studies, UV doses must
be wavelength weighted using the CIE reference action
spectrum for erythema [25]. Twenty-four hours after UV
exposure, trained observers determine the MED by visual
assessment using a scale where 1 MED is deﬁned as pink
erythema with at least one distinct border.
Obviously, this determination can be subjective and is
highly dependent on a trained observer. There are a few
limitations with assessing the MED visually especially when
considering varying illumination conditions, environmental
temperatures, and viewing angles during the visual assess-
ment at diﬀerent clinical sites. To address this issue, in the
case of sunscreens there are some standard requirements
regarding lighting conditions that have been set forth in the
US FDA Sunscreen Monograph [26] that can also be applied
to HA evaluation. In addition, increased melanin content
presents a challenge when discriminating erythema, and this
isanareawherediﬀusereﬂectancespectroscopy(DRS)excels
overvisualevaluation.Somepioneeringworkwasperformed
over 2 decades ago that deﬁned the use of CIE L∗a∗b∗ color
space system variables and transformed them into a vector
representationofskinpigmentationdeﬁnedastheindividual
typologyangle(ITA=[arctan(L∗−50/b)] ×180/Pi)[27,28].
However, this CIE L∗a∗b∗ system is inadequate to dis-
criminate erythema masked by higher melanin content, and
therefore measuring skin chromophores, such as melanin,
oxyhemoglobin and deoxyhemoglobin, by DRS is highly
desirable for deﬁning the MED noninvasively. Severalstudies
have been published on the use of DRS, which prove that
it can be applied as an adjunct to aid in the prediction and
measurement of MEDs for HA UV eﬀects [29–31].
In the past decade, gene array technologies have changed
the way we evaluate skin biology responses by allowing us
insight into the global genome proﬁle at particular moments
in time and under speciﬁc environmental conditions. Recen-
ly through the use of microarrays the diﬀerent spectral res-
ponses from repetitive UVA and/or UVB exposure of human
skin were characterized [32]. Further, acute doses with
full-spectrum solar-simulated radiation and solar-simulated4 Dermatology Research and Practice
UVA with or without SPF 15 sunscreen treatment were also
assessed [33]. However, there are virtually no published
microarray studies evaluating HA formulations with relation
to the eﬀects of UV on skin, but there have been some
interesting studies that have evaluated skin responses with
or without UV when pretreated with skin lightening or
irritating compounds [34, 35]. This is an area that has great
potentialtobecomethemethodofchoiceforsafetyscreening
of cosmetic preparations. Approaches to evaluate global gene
expression patterns correlated to cosmetic outcomes may
also provide insights into the proﬁles of responders and
nonresponders to formulations containing HAs.
5. Effects of HAs on Pigmentation
HAs have also been shown to have signiﬁcant eﬀects on skin
pigmentation. α-HAs, such as glycolic acid and lactic acid,
have been shown to be eﬀective in treating various types
of hyperpigmentary lesions, such as photoaging [36, 37],
melasma [38–40], solar lentigines [41, 42], and postinﬂam-
matory hyperpigmentation [43]. The proposed mechanism
underlying those eﬀects is thought to involve epidermal
remodeling and accelerated desquamation, which results in
a more rapid and eﬃcient dispersion of existing pigment.
Usukietal.reportedaninvitrostudy[44]whichshowedthat
glycolic acid and lactic acid suppress melanin synthesis by
inhibiting tyrosinase activity, the critical enzyme involved in
melanin synthesis, in human and in mouse melanoma cells.
Both the transcription and translation of tyrosinase were
decreasedsigniﬁcantly,whichresultedinthereducedenzyme
function but with no signiﬁcant eﬀect on cell growth. Based
on that in vitro analysis, increased epidermal turnover and
inhibition of melanin formation were surmised to be the
eﬀects of glycolic acid and lactic acid treatment. The poten-
tial eﬀects of HAs on skin pigmentation resulting from UV
exposure (i.e., tanning) have been less well characterized.
UV-induced eﬀects of glycolic acid on skin pigmentation
were investigated in both Asian and Caucasian subjects who
received UVA and UVB irradiations on both sides of their
lower backs, and on the contralateral extensor forearms [45].
Treatmentswereappliedoncedailyfor1weekandthentwice
daily for 7 weeks; as a control, a placebo gel was applied on
the opposite sides [45]. Areas pretreated with glycolic acid
had increased UVB-induced tanning on the forearm and the
lower back in both races compared to the untreated control
areas. In contrast, only Asian subjects showed increases in
tanningontheexteriorforearms.TheuseofPHAsonphoto-
aged skin in several skin phototypes has also been recently
investigated [46]; the results show that, in addition to several
beneﬁcial eﬀects on skin physiology, PHAs elicit a signiﬁcant
skin lightening, although the mechanism by which that
occurs has not yet been elucidated. Glycolic acid has recently
been assessed with respect to its eﬃcacy when used in
combination with skin peels elicited by nonablative lasers,
intense pulsed light, and trichloroacetic acid. That study
showed that glycolic acid had synergistic eﬀects when used
with those other treatments to improve skin parameters,
including lightening of the skin and smoothing uneven
pigmentation [47]. The majority of those clinical studies
were performed with subjects having skin types I–III, and to
address similar issues of the eﬀects of HAs on subjects with
darker skin types investigations using darker skin types (IV–
VI) are needed.
6. Conclusions
HAsandrelatedproducts,suchasPHAsandPHBAs,arenow
standard ingredients in cosmetics and skin care products, as
well as in a number of dermatologic formulations. They can
be applied in various types of vehicles, integrated into lipo-
somes, or in a variety of nanoparticle formulations. We still
need more information about the safety of the long-term use
of these products. This is particularly evident for the eﬀects
of HAs on sun-exposed skin. Topically applied HAs can
interact with many basic molecular processes occurring in
mammalianskin(summarizedinTable 1of [1]),suchascell
proliferation, cytokine production, apoptosis, antioxidants
potencies, and others. Recent investigations clearly demon-
strated that the eﬀects of topically applied HAs are not
limited exclusively to their often cited keratolytic properties.
Newmethodologies,someofthemincludedinthispaper,are
neededandarealreadybeingappliedindesigningcontempo-
rary cosmetic products, as well as in assessing their safety.
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